These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 23992163)

  • 81. The Higher Number and Longer Duration of Kenogen Hairs Are the Main Cause of the Hair Rarefaction in Androgenetic Alopecia.
    Guarrera M; Rebora A
    Skin Appendage Disord; 2019 Apr; 5(3):152-154. PubMed ID: 31049336
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Hair loss. What causes it and what can be done about it.
    Burke KE
    Postgrad Med; 1989 May; 85(6):52-8, 67-73, 77. PubMed ID: 2652126
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Aetiology and pathophysiology of hair loss.
    Dawber RP
    Dermatologica; 1987; 175 Suppl 2():23-8. PubMed ID: 3319730
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Female androgenetic alopecia, a survey of causes and therapeutic options].
    Duchková H; Hašková M
    Cas Lek Cesk; 2015; 154(2):90-4. PubMed ID: 25994911
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Multifactorial classification of male and female androgenetic alopecia.
    Bouhanna P
    Dermatol Surg; 2000 Jun; 26(6):555-61. PubMed ID: 10848937
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Caffeine and Its Pharmacological Benefits in the Management of Androgenetic Alopecia: A Review.
    Völker JM; Koch N; Becker M; Klenk A
    Skin Pharmacol Physiol; 2020; 33(3):93-109. PubMed ID: 32599587
    [TBL] [Abstract][Full Text] [Related]  

  • 87. New Treatments for Hair Loss.
    Vañó-Galván S; Camacho F
    Actas Dermosifiliogr; 2017 Apr; 108(3):221-228. PubMed ID: 28061966
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Proprietary Herbal Extract Downregulates the Gene Expression of IL-1α in HaCaT Cells: Possible Implications Against Nonscarring Alopecia.
    Pekmezci E; Dundar C; Turkoglu M
    Med Arch; 2018 Apr; 72(2):136-140. PubMed ID: 30302033
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Pharmacologic interventions in aging hair.
    Trüeb RM
    Clin Interv Aging; 2006; 1(2):121-9. PubMed ID: 18044109
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Mesotherapy With Dutasteride for Androgenetic Alopecia: A Retrospective Study in Real Clinical Practice.
    Saceda-Corralo D; Moustafa F; Moreno-Arrones Ó; Jaén-Olasolo P; Vañó-Galván S; Camacho F
    J Drugs Dermatol; 2022 Jul; 21(7):742-747. PubMed ID: 35816059
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Medicinal Plants for the Treatment of Hair Loss and the Suggested Mechanisms.
    Shen YL; Li XQ; Pan RR; Yue W; Zhang LJ; Zhang H
    Curr Pharm Des; 2018; 24(26):3090-3100. PubMed ID: 30205796
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The physiological and pharmacological roles of prostaglandins in hair growth.
    Shin DW
    Korean J Physiol Pharmacol; 2022 Nov; 26(6):405-413. PubMed ID: 36302616
    [TBL] [Abstract][Full Text] [Related]  

  • 93. An update on cutaneous aging treatment using herbs.
    Kanlayavattanakul M; Lourith N
    J Cosmet Laser Ther; 2015; 17(6):343-52. PubMed ID: 25968169
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Efficacy of Intralesional and Oral Dutasteride in the Treatment of Androgenetic Alopecia: A Systematic Review.
    Herz-Ruelas ME; Álvarez-Villalobos NA; Millán-Alanís JM; de León-Gutiérrez H; Ocampo-Garza SS; Gómez-Flores M; Grimalt R
    Skin Appendage Disord; 2020 Nov; 6(6):338-345. PubMed ID: 33313048
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Chemical agents and peptides affect hair growth.
    Uno H; Kurata S
    J Invest Dermatol; 1993 Jul; 101(1 Suppl):143S-147S. PubMed ID: 8326148
    [TBL] [Abstract][Full Text] [Related]  

  • 96. RF-Mesotherapy With Dutasteride: A Future Alternative Treatment for Androgenetic Alopecia.
    Reguero-Del Cura L; Durán-Vian C; de Quintana-Sancho A
    Actas Dermosifiliogr (Engl Ed); 2020 Jun; 111(5):419-420. PubMed ID: 32416936
    [No Abstract]   [Full Text] [Related]  

  • 97. Clinical Evidence of Increase in Hair Growth and Decrease in Hair Loss without Adverse Reactions Promoted by the Commercial Lotion ECOHAIR®.
    Alonso MR; Anesini C
    Skin Pharmacol Physiol; 2017; 30(1):46-54. PubMed ID: 28226316
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Clinical Patterns of Hair Loss in Men: Is Dihydrotestosterone the Only Culprit?
    Kash N; Leavitt M; Leavitt A; Hawkins SD; Roopani RB
    Dermatol Clin; 2021 Jul; 39(3):361-370. PubMed ID: 34053589
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Association between smoking and hair loss: another opportunity for health education against smoking?
    Trüeb RM
    Dermatology; 2003; 206(3):189-91. PubMed ID: 12673073
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Nanostructured Drug Delivery Systems for Targeting 5-α-Reductase Inhibitors to the Hair Follicle.
    Tampucci S; Paganini V; Burgalassi S; Chetoni P; Monti D
    Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.